[Characteristics of hepatitis and influenza antivirals: update 2009]

Ester Lopez-Suñé; Montse Tuset; Montse Laguno; Asunción Moreno; José M Miró

doi:10.1016/j.eimc.2010.02.001

[Characteristics of hepatitis and influenza antivirals: update 2009]

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):253.e1-17. doi: 10.1016/j.eimc.2010.02.001. Epub 2010 Apr 14.

[Article in Spanish]

Authors

Ester Lopez-Suñé¹, Montse Tuset, Montse Laguno, Asunción Moreno, José M Miró

Affiliation

¹ Servicio de Farmacia, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic Universitari, Barcelona, España. eslopez@clinic.ub.es

PMID: 20395018
DOI: 10.1016/j.eimc.2010.02.001

Abstract

This article aims to review hepatitis B and C and influenza infections and to summarise the main characteristics of the antiviral drugs available to treat those infections in adults. The review of each drug focuses on dosage depending on treatment indication, dosage adjustment in renal or hepatic impairment, main pharmacokinetic features and the most significant adverse effects and drug interactions.

Publication types

English Abstract
Review

MeSH terms

Adult
Antiviral Agents / administration & dosage
Antiviral Agents / adverse effects
Antiviral Agents / classification
Antiviral Agents / pharmacokinetics
Antiviral Agents / pharmacology
Antiviral Agents / therapeutic use*
Drug Interactions
Drug Therapy, Combination
Drugs, Investigational / therapeutic use
Female
Hepatitis B / drug therapy*
Hepatitis C / drug therapy*
Humans
Influenza, Human / drug therapy*
Male
Pregnancy
Pregnancy Complications, Infectious / drug therapy

Substances

Antiviral Agents
Drugs, Investigational